#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4620360	F	Osteo-blastogenic activity in mouse calvarial osteoblast assessed as upregulation of BMP2 mRNA expression at 1 pM to 100 pM measured after 48 hrs by qPCR analysis	Mus musculus	1	ALA4619727	cell-based format	Scientific Literature
2.	ALA4620363	B	Induction of ESR2-mediated osteoblast differentiation in mouse calvarial osteoblast assessed as increase in ALP activity at 1 pM measured after 48 hrs by spectrophotometric analysis	Mus musculus	4	ALA4619727	cell-based format	Scientific Literature
3.	ALA4620364	F	Upregulation of ALP mRNA expression in mouse calvarial osteoblast at 1 pM to 100 pM measured after 24 to 48 hrs by qPCR analysis	Mus musculus	1	ALA4619727	cell-based format	Scientific Literature
4.	ALA4620365	F	Osteo-blastogenic activity in mouse calvarial osteoblast assessed as upregulation of Runx2 mRNA expression at 1 pM to 100 pM measured after 48 hrs by qPCR analysis	Mus musculus	1	ALA4619727	cell-based format	Scientific Literature
5.	ALA4620366	B	Induction of ESR2-mediated osteoblast differentiation in mouse calvarial osteoblast assessed as formation of mineralized nodule at 1 to 10 uM measured after 21 days by alizarin red staining based assay	Mus musculus	1	ALA4619727	cell-based format	Scientific Literature
6.	ALA4620367	F	Anti-osteoporosis activity in ovariectomized BALB/c mouse assessed as increase in femur bone volume density at 1 to 5 mg/kg, po via gavage administered for 1 month by microCT imaging analysis	Mus musculus	1	ALA4619727	organism-based format	Scientific Literature
7.	ALA4620368	F	Anti-osteoporosis activity in ovariectomized BALB/c mouse assessed as increase in trabecular number in femur bone at 1 to 5 mg/kg, po via gavage administered for 1 month by microCT imaging analysis	Mus musculus	1	ALA4619727	organism-based format	Scientific Literature
8.	ALA4620369	F	Anti-osteoporosis activity in ovariectomized BALB/c mouse assessed as increase in trabecular thickness in femur bone at 1 to 5 mg/kg, po via gavage administered for 1 month by microCT imaging analysis	Mus musculus	1	ALA4619727	organism-based format	Scientific Literature
9.	ALA4620370	F	Anti-osteoporosis activity in ovariectomized BALB/c mouse assessed as reduction in trabecular spacing in femur bone at 1 to 5 mg/kg, po via gavage administered for 1 month by microCT imaging analysis	Mus musculus	1	ALA4619727	organism-based format	Scientific Literature
10.	ALA4620371	F	Anti-osteoporosis activity in ovariectomized BALB/c mouse assessed as reduction in trabecular pattern factor in femur bone at 1 to 5 mg/kg, po via gavage administered for 1 month by microCT imaging analysis	Mus musculus	1	ALA4619727	organism-based format	Scientific Literature
11.	ALA4620377	F	Anti-osteoporosis activity in ovariectomized BALB/c mouse at 5 mg/kg, po via gavage administered for 1 month by microCT imaging analysis	Mus musculus	1	ALA4619727	organism-based format	Scientific Literature
12.	ALA4620378	F	Upregulation of ESR1 protein level in mouse calvarial osteoblast at 1 to 100 pM measured after 48 hrs by Western blot analysis	Mus musculus	1	ALA4619727	cell-based format	Scientific Literature
13.	ALA4620379	F	Upregulation of ESR2 protein level in mouse calvarial osteoblast at 1 to 100 pM measured after 48 hrs by Western blot analysis	Mus musculus	1	ALA4619727	cell-based format	Scientific Literature
14.	ALA4620380	F	Cytotoxicity against human MCF7 cells assessed as cell growth inhibition at 30 ug/ml by MTT assay relative to control	Homo sapiens	10	ALA4619727	cell-based format	Scientific Literature
15.	ALA4620381	A	Cytotoxicity against peritoneal macrophage cells (unknown origin) at 5 to 20 uM by MTT assay	Not specified	1	ALA4619727	cell-based format	Scientific Literature